Prostate Cancer Foundation of Australia

The Prostate Cancer Foundation And The Movember Foundation Announce 2018 Challenge Awards Winners

Retrieved on: 
Thursday, August 16, 2018

For more than a decade, the PCF and the Movember Foundation have partnered to defeat prostate cancer.

Key Points: 
  • For more than a decade, the PCF and the Movember Foundation have partnered to defeat prostate cancer.
  • To date, the Movember Foundation has contributed more than $50 million to the PCF to fund programs to advance top prostate cancer research priorities.
  • "The Prostate Cancer Foundation values its ongoing relationship with the Movember Foundation and is greatly appreciative of their generous donation.
  • The Prostate Cancer Foundation (PCF) is the world's leading philanthropic organization funding and accelerating prostate cancer research.

The National Football League Alumni, Cancer Treatment Centers of America®, LabCorp® and Health Testing Centers Team Up to Offer Prostate Cancer Screenings in September

Retrieved on: 
Thursday, August 16, 2018

Beginning in September (Prostate Cancer Awareness Month), the Prostate Pep Talk messaging will encourage men to get screened for prostate cancer.

Key Points: 
  • Beginning in September (Prostate Cancer Awareness Month), the Prostate Pep Talk messaging will encourage men to get screened for prostate cancer.
  • Eligible men may order their free or discounted PSA screening by visiting Prostate Pep Talk or Health Testing Centers - Prostate Pep Talk .
  • Health Testing Centers is a mission-driven company on the forefront of movement toward transparency and greater control in health care through personalized preventive care.
  • Cancer Treatment Centers of America Global, Inc. (CTCA) is a comprehensive cancer care network of hospitals and outpatient care centers in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa.

European Prostate Cancer Market Outlook to 2026

Retrieved on: 
Friday, July 13, 2018

The research provides insights into Prostate Cancer epidemiology, Prostate Cancer diagnosed patients, and Prostate Cancer treatment rate for EU5 countries.

Key Points: 
  • The research provides insights into Prostate Cancer epidemiology, Prostate Cancer diagnosed patients, and Prostate Cancer treatment rate for EU5 countries.
  • The research measures key indicators including prevalence of Prostate Cancer derived from epidemiological analysis, patients diagnosed with Prostate Cancer, and patients treated with a drug therapy.
  • The research study helps executives estimate Prostate Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks.
  • The research provides estimates and forecasts of Prostate Cancer prevalence, Prostate Cancer diagnosis rate, and Prostate Cancer treatment rate for the period 2017-2026.

New Cancer Test Improves Diagnosis of Prostate Cancer, Product Significantly Improves Diagnostics for Men's Health Care

Retrieved on: 
Friday, May 4, 2018

The company's productProstacis a test kit that will significantly change the way medical professionals administer prostate cancer testing.

Key Points: 
  • The company's productProstacis a test kit that will significantly change the way medical professionals administer prostate cancer testing.
  • "Prostac is a non-invasive, urine-based test that will resolve numerous flaws in existing prostate cancer screening methods," said Charles Oyesile, M.D., Ph.D., NucleoBioInc.
  • Prostac is going to drastically improve health care for men and dramatically disrupt the health care industry."
  • The test kit will contain several components and will be available to physicians and health care professionals at medical facilities that offer prostate cancer screening and men's health care.